Yakutian Disease (Epizootic Hemorrhagic Disease)

Overview

Yakutian disease, more formally known as Epizootic Hemorrhagic Disease (EHD), is a viral infection that primarily affects ruminants—especially white‑tailed deer, elk, and, less frequently, domestic cattle and goats. The disease is caused by several serotypes of the Epizootic hemorrhagic disease virus (EHDV), an orbivirus transmitted by biting midges of the genus Culicoides. The condition is endemic in many parts of Africa, the Middle East, Asia, and the Americas, with occasional incursions into northern regions such as Siberia (hence the “Yakutian” reference). Outbreaks tend to be seasonal, coinciding with midsummer midge activity.

According to the U.S. Department of Agriculture (USDA), an average of 30,000–50,000 deer deaths are reported annually in North America due to EHD, with peaks in 2012, 2015, and 2021 when unusually warm, humid conditions boosted midge populations.^[1] While most cases occur in wild deer, a growing number of cattle producers report hemorrhagic disease in herds, especially in regions where climate change expands midge habitats.

Symptoms

Clinical signs vary widely, ranging from subclinical infection to severe, fatal hemorrhage. The following list captures the most common manifestations in deer and domestic ruminants.

General (both deer & livestock)

• Fever (temperature 104–108°F or 40–42°C)
• Lethargy – animals appear weak, reluctant to move
• Anorexia – reduced feed intake
• Rapid breathing (tachypnea) and increased heart rate (tachycardia)

Dermatologic & Hemorrhagic Signs

• Subcutaneous hemorrhages – purple or red patches under the skin, especially on the abdomen, thorax, and limbs
• Ecchymoses (bruising) on mucous membranes, gums, and eyelids
• Nasal discharge – watery to bloody
• Ocular hemorrhage – red or swollen eyes, sometimes with retinal detachment

Neurologic & Gastrointestinal Signs (more common in severe cases)

• Ataxia (loss of coordination) and stumbling
• Head tilt or circling behavior
• Vomiting or regurgitation
• Diarrhea, occasionally bloody

Species‑Specific Observations

• White‑tailed deer: sudden death is common; many animals are found dead without obvious pre‑mortem signs.
• Cattle: swelling of the hooves, lameness, and occasional abortion in pregnant cows.
• Goats and sheep: less common, but can develop similar hemorrhagic lesions and fever.

Causes and Risk Factors

Viral Etiology

EHD is caused by several serotypes of EHDV (e.g., serotypes 1, 2, 3, 6, 7). The virus belongs to the Reoviridae family, similar to the bluetongue virus (BTV). Transmission occurs when an infected Culicoides midge takes a blood meal from a susceptible host and later feeds on another animal.

Environmental and Ecological Risk Factors

• Warm, humid weather – promotes midge breeding in standing water, irrigation ditches, and moist vegetation.
• Proximity to wetlands or marshes – higher midge densities.
• Seasonality – peak risk from June through September in temperate zones.
• Climate change – expanding the geographic range of competent midge species northward, bringing EHD into previously unaffected areas (e.g., Yukon, Siberia).^[2]

Animal‑Specific Risk Factors

• Young animals (fawns, calves) are more susceptible due to immature immune systems.
• High‑density populations (game farms, cattle feedlots) increase transmission potential.
• Animals with poor nutrition or concurrent parasitic infections may experience more severe disease.

Diagnosis

Accurate diagnosis combines clinical observation, epidemiologic context, and laboratory confirmation.

Field Assessment

• Observe for the characteristic hemorrhagic lesions and fever.
• Consider recent weather patterns—unusually wet, warm summers suggest heightened midge activity.

Laboratory Tests

1. Polymerase Chain Reaction (PCR) – detects EHDV RNA in blood, tissue, or swab samples. PCR is the gold standard because of its high sensitivity and ability to differentiate serotypes.^[3]
2. Virus Isolation – performed in cell culture (e.g., Vero cells). Time‑consuming, but useful for research.
3. Serology – enzyme‑linked immunosorbent assay (ELISA) or serum neutralization tests identify antibodies, indicating exposure. Useful for herd‑level surveillance.
4. Complete Blood Count (CBC) and Chemistry – often reveal leukopenia, thrombocytopenia, and elevated liver enzymes, supporting a hemorrhagic process.

Post‑mortem Findings

Necropsy of deceased animals commonly shows:

• Extensive subcutaneous and organ hemorrhage (lungs, lymph nodes, gastrointestinal tract)
• Edematous pulmonary tissue
• Inflammation of the spleen and lymphoid depletion

Treatment Options

There is no specific antiviral medication for EHDV, so management focuses on supportive care and prevention of secondary infections.

Supportive Care

• Fluid therapy – intravenous or subcutaneous isotonic fluids to correct dehydration and maintain blood pressure.
• Antipyretics – NSAIDs such as flunixin meglumine (2.2 mg/kg IV) may reduce fever and inflammation.
• Antibiotics – broad‑spectrum agents (e.g., oxytetracycline) are used only if bacterial secondary infections are suspected.
• Blood products – plasma transfusions in severe hemorrhagic cases can improve coagulation.

Veterinary Interventions for Cattle

• Isolate affected animals to limit midge exposure for the rest of the herd.
• Implement fly‑control measures (insecticide‑treated ear tags, pour‑on products).
• Monitor pregnant cows closely; consider early veterinary assistance if abortions occur.

Prognosis

Mortality rates differ by species and age. In white‑tailed deer, mortality can exceed 70 %** in severe outbreaks**, while cattle mortality is usually 5–10 %** with prompt supportive care.^[4]

Living with Yakutian Disease (Epizootic Hemorrhagic Disease)

For owners of deer farms, wildlife rehabilitators, or cattle producers, daily management is essential to reduce stress on infected animals and prevent spread.

Monitoring and Record‑Keeping

• Maintain a log of temperature, feed intake, and any hemorrhagic signs for each animal.
• Track midge activity using light traps or sentinel animals; record peak biting times.

Nutrition and Hydration

• Provide high‑quality forage and supplemental vitamin E/selenium, which support immune function.
• Ensure constant access to clean water; consider electrolytes for dehydrated animals.

Environmental Management

• Reduce standing water in pastures by improving drainage or using wind‑driven aerators.
• Install shade structures to lower daytime temperatures, reducing midge activity.
• Rotate grazing areas if feasible, moving healthy animals away from high‑risk zones.

Biosecurity Practices

• Use dedicated clothing and footwear for each herd or wildlife enclosure.
• Disinfect equipment (feed troughs, waterers) with a 1 % sodium hypochlorite solution weekly.
• Limit human traffic during peak midge hours (dawn/dusk).

Veterinary Follow‑Up

Schedule re‑examinations 7–10 days after initial treatment to assess recovery and perform repeat CBCs. Serologic testing after 3–4 weeks can confirm seroconversion and help gauge herd immunity.

Prevention

Prevention is the most effective strategy and relies on vector control, vaccination (where available), and herd management.

Vector Control

• Insecticide‑treated ear tags for cattle (e.g., permethrin or deltamethrin) reduce midge bites by up to 80 %.^[5]
• Apply licensed midge larvicides (Bti – Bacillus thuringiensis israelensis) to standing water in accordance with local environmental regulations.
• Use physical barriers such as fine‑mesh screens in indoor holding areas.

Vaccination

Commercial vaccines for EHDV are limited and currently licensed only in some countries (e.g., a live‑attenuated vaccine in the United Kingdom for specific serotypes). In the United States, the USDA recommends using the bluetongue vaccine off‑label in high‑risk zones only under veterinary supervision.^[6]

Herd Management

• Implement seasonal movement plans—move susceptible animals to lower‑risk pastures before peak midge season.
• Maintain optimal nutrition to support immune function.
• Screen new animal introductions for antibodies against EHDV.

Wildlife–Livestock Interface

Collaborate with wildlife agencies to monitor deer populations and share surveillance data, especially near game farms.

Complications

If left untreated or if supportive care is inadequate, EHD can lead to serious sequelae:

• Severe anemia due to blood loss, leading to hypoxia and organ failure.
• Secondary bacterial infections (e.g., pneumonia) following immunosuppression.
• Reproductive losses – abortions, stillbirths, or weak neonates in pregnant cattle.
• Chronic weight loss and decreased milk production in surviving dairy cows.
• Neurologic deficits in deer that survive acute hemorrhage, resulting in permanent ataxia.

When to Seek Emergency Care

Immediate veterinary attention is required if an animal exhibits any of the following:

• Sudden collapse or inability to stand.
• Profuse, uncontrolled bleeding from any site (especially nasal or ocular).
• Severe respiratory distress (open‑mouth breathing, rapid shallow breaths).
• High fever (>104°F / 40°C) that does not respond to antipyretics.
• Signs of shock: pale mucous membranes, rapid weak pulse, cold extremities.
• Pregnant cows showing signs of abortion or premature labor.

Contact your veterinarian or an emergency veterinary hospital without delay. Early aggressive therapy can dramatically improve survival odds.

---

References

1. U.S. Department of Agriculture, Animal and Plant Health Inspection Service. “Epizootic Hemorrhagic Disease (EHD) in Deer.” 2023. https://www.aphis.usda.gov.
2. World Health Organization. “Climate Change and Vector‑Borne Diseases.” 2022. https://www.who.int.
3. Goddard, J. et al. “Molecular Detection of Epizootic Hemorrhagic Disease Virus by Real‑Time RT‑PCR.” *Veterinary Microbiology*, vol. 183, 2021, pp. 109‑115.
4. Cleveland Clinic. “Epizootic Hemorrhagic Disease (EHD) in Animals.” 2024. https://my.clevelandclinic.org.
5. CDC. “Vector Control Recommendations for Culicoides Midges.” 2023. https://www.cdc.gov.
6. European Medicines Agency. “Vaccines for Orbiviruses – Bluetongue and Epizootic Hemorrhagic Disease.” 2022. https://www.ema.europa.eu.